Abstract
Esophageal and esophagogastric adenocarcinoma is highly prevalent in the Western populations and is a major cause of cancer-related morbidity and mortality worldwide. The incidence of esophageal adenocarcinoma is rapidly rising in the Western populations. The major predisposing diseases and pathogenesis (gastro-esophageal reflux disease, Barrett esophagus, and dysplasia) of the cancer are well known. There is an urgent need for works of the multidisciplinary teams (clinical, pathological, the molecular biology and translational research) for improved outcomes of patients with this cancer.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Lam KY, Ma L (1997) Pathology of esophageal cancers: local experience and current insights. Chin Med J 110:459–464
Rubenstein JH, Shaheen NJ (2015) Epidemiology, diagnosis, and management of esophageal adenocarcinoma. Gastroenterology 149:302–317
Runge TM, Abrams JA, Shaheen NJ (2015) Epidemiology of Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am 44: 203–231
Lagergren J, Lagergren P (2013) Recent developments in esophageal adenocarcinoma. CA Cancer J Clin 63:232–248
Butt J, Kandel G (2014) Barrett esophagus: when to endoscope. Clin Endosc 47:40–46
Joo MK, Park JJ, Chun HJ (2018) Additional benefits of routine drugs on gastrointestinal cancer: statins, metformin, and proton pump inhibitors. Dig Dis 36:1–14
Beales IL, Dearman L, Vardi I, Loke Y (2016) Reduced risk of Barrett’s esophagus in statin users: case-control study and meta-analysis. Dig Dis Sci 61:238–246
Gharahkhani P, Fitzgerald RC, Vaughan TL et al (2016) Genome-wide association studies in esophageal adenocarcinoma and Barrett’s esophagus: a large-scale meta-analysis. Lancet Oncol 17:1363–1373
Kadota T, Fujii S, Oono Y, Imajoh M, Yano T, Kaneko K (2016) Adenocarcinoma arising from heterotopic gastric mucosa in the cervical esophagus and upper thoracic esophagus: two case reports and literature review. Expert Rev Gastroenterol Hepatol 10:405–414
Ning B, Abdelfatah MM, Othman MO (2017) Endoscopic submucosal dissection and endoscopic mucosal resection for early stage esophageal cancer. Ann Cardiothorac Surg 6:88–98
Barnes JA, Willingham FF (2015) Endoscopic management of early esophageal cancer. J Clin Gastroenterol 49:638–646
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Lam, A.K. (2018). Introduction: Esophageal Adenocarcinoma: Updates of Current Status. In: Lam, A. (eds) Esophageal Adenocarcinoma. Methods in Molecular Biology, vol 1756. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7734-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7734-5_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7733-8
Online ISBN: 978-1-4939-7734-5
eBook Packages: Springer Protocols